coronavirus
frequent
caus
commun
acquir
upper
respiratori
tract
infect
novel
coronaviru
strain
discov
report
novemb
subsequ
call
middl
east
respiratori
syndrom
coronaviru
mer
cov
pneumonia
caus
mer
cov
associ
sever
morbid
mortal
immunocompet
popul
howev
clinic
pictur
vari
wide
rang
asymptomat
carrier
state
sever
rapidli
fatal
pneumonia
certain
risk
factor
develop
mer
cov
pneumonia
poor
outcom
renal
diseas
identifi
howev
data
clinic
pictur
solid
organ
transplant
recipi
effect
immunosuppress
regimen
clinic
cours
mer
cov
infect
lack
one
previous
report
case
renal
transplant
recipi
mer
cov
pneumonia
report
two
case
mer
cov
pneumonia
renal
transplant
recipi
variabl
clinic
present
outcom
gentleman
underw
live
relat
renal
transplant
septemb
due
hypertens
nephrosclerosi
present
emerg
depart
march
complain
gener
fatigu
durat
follow
sore
throat
short
breath
start
day
prior
present
complain
cough
fever
diarrhea
abdomin
pain
vomit
histori
contact
similarli
ill
febril
patient
admiss
requir
lmin
oxygen
facemask
maintain
oxygen
satur
moreov
oliguria
laboratori
test
reveal
white
blood
count
hemoglobin
gdl
platelet
count
absolut
neutrophil
count
absolut
lymphocyt
count
lactat
dehydrogenas
ul
alanin
aminotransferas
ul
aspart
aminotransferas
ul
patient
found
acut
renal
failur
admiss
serum
creatinin
mgdl
calcul
creatinin
clearanc
admiss
mlmin
chest
reveal
diffus
bilater
infiltr
figur
regimen
consist
cyclosporin
azathioprin
mg
daili
prednison
mg
daili
continu
venoven
hemodialysi
hemofiltr
promptli
start
low
hemoglobin
attribut
upper
gastrointestin
bleed
evidenc
posit
stool
occult
blood
test
upper
gastrointestin
scope
reveal
gastric
wall
inflamm
patient
requir
total
unit
pack
red
blood
cell
transfus
throughout
admiss
initi
receiv
ceftriaxon
levofloxacin
trimethoprimsulfamethoxazol
initi
empir
treatment
possibl
pneumocysti
jirovecii
pneumonia
oseltamivir
possibl
influenza
infect
antimicrobi
dose
adjust
patient
creatinin
clearanc
given
patient
critic
condit
broader
antibacteri
coverag
consist
imipenem
vancomycin
addit
trimethoprimsulfamethoxazol
ad
day
later
replac
ceftriaxon
two
day
admiss
white
blood
count
drop
granulocyt
coloni
stimul
factor
initi
mg
subcutan
daili
day
trimethoprimsulfamethoxazol
discontinu
viral
pneumonia
due
mer
cov
suspect
day
admiss
nasopharyng
swab
well
blood
qualit
revers
transcript
polymeras
chain
reaction
assay
mer
cov
posit
patient
clinic
condit
deterior
necessit
endotrach
intub
result
mer
cov
pcr
becam
avail
day
later
pegyl
interferon
subcutan
weekli
addit
ribavirin
mg
load
dose
follow
mg
oral
twice
daili
initi
bacteri
cultur
sputum
blood
urin
neg
patient
condit
continu
worsen
eventu
succumb
infect
pass
away
day
diagnosi
mer
cov
pneumonia
made
gentleman
live
relat
renal
transplant
march
receiv
antithymocyt
globulin
induct
therapi
mg
intraven
iv
daili
day
prior
date
transplant
follow
mg
iv
daili
day
posttranspl
posttranspl
cours
complic
hydronephrosi
graft
due
lower
ureter
strictur
requir
nephrostomi
tube
insert
march
patient
discharg
home
april
immunosuppress
regimen
consist
tacrolimu
mg
oral
twice
daili
mycophenol
mofetil
gm
twice
daili
prednison
mg
daili
antimicrobi
prophylaxi
consist
trimethoprimsulfamethoxazol
valganciclovir
admit
april
fatigu
short
breath
product
cough
bloodi
sputum
day
temperatur
admiss
blood
examin
reveal
white
blood
cell
count
absolut
neutrophil
count
absolut
lymphocyt
count
hemoglobin
gdl
platelet
count
lactat
dehydrogenas
ul
serum
creatinin
mgdl
tacrolimu
level
chest
admiss
normal
figur
nasopharyng
swab
admiss
posit
mer
cov
bacteri
cultur
sputum
blood
neg
urin
cultur
reveal
enterobact
cloaca
antibacteri
therapi
meropenem
levofloxacin
initi
mycophenol
mofetil
dose
reduc
mg
oral
twice
daili
patient
stabl
admiss
cours
symptom
improv
fever
resolv
discharg
home
april
pneumonia
due
mer
cov
associ
high
rate
mortal
reach
patient
comorbid
condit
particularli
renal
diseas
tend
wors
outcom
due
scarciti
data
howev
clinic
present
well
effect
solid
organ
transplant
along
immunosuppress
regimen
sever
outcom
mer
cov
pneumonia
remain
unknown
report
two
case
mer
cov
infect
renal
transplant
recipi
variabl
clinic
present
diagnosi
confirm
use
two
qualit
assay
one
target
region
upstream
e
gene
upe
target
region
within
open
read
frame
blood
done
plasma
blood
done
case
difficult
make
conclus
regard
signific
posit
blood
mer
cov
infect
base
singl
case
whether
blood
mer
use
prognost
indic
worth
investig
larg
cohort
number
patient
small
abl
discern
whether
natur
histori
mer
cov
infect
alter
transplant
recipi
howev
appear
may
similar
nontranspl
popul
base
variabl
clinic
present
two
case
outcom
death
patient
present
sever
pneumonia
failur
young
patient
pneumonia
evidenc
normal
chest
surviv
recov
despit
receiv
globulin
day
prior
admiss
mer
infect
import
note
although
fever
includ
world
health
organ
center
diseas
control
prevent
mer
case
definit
absent
case
therefor
absenc
fever
transplant
recipi
preclud
investig
mer
infect
patient
otherwis
fit
mer
infect
definit
poor
outcom
first
patient
may
relat
patient
acut
renal
failur
probabl
part
relat
signific
volum
deplet
caus
sever
anemia
addit
viral
tropism
uroepitheli
cell
implic
caus
commonli
observ
acut
renal
failur
patient
mer
cov
pneumonia
may
play
role
caus
acut
renal
failur
patient
well
attempt
treat
sever
mer
cov
pneumonia
interferon
combin
ribavirin
initi
base
previou
vitro
studi
interferon
found
lead
dose
depend
reduct
number
genom
copi
mer
cov
well
reduct
cytopath
effect
magnifi
combin
ribavirin
vitro
model
led
author
test
combin
anim
model
macaqu
h
inocul
mer
cov
favor
outcom
choic
interferon
instead
interferon
due
lack
interferon
avail
failur
regimen
demonstr
case
seri
consist
five
patient
sever
mer
cov
pneumonia
poor
outcom
combin
start
late
case
case
seri
minimum
day
pneumonia
whether
poor
outcom
case
relat
delay
administr
treatment
due
lack
true
vivo
efficaci
human
difficult
conclud
absenc
control
studi
moreov
recent
vitro
studi
demonstr
interferon
superior
cov
activ
compar
interferon
evidenc
lower
whether
factor
led
patient
poor
outcom
whether
factor
involv
imposs
conclud
base
limit
data
avail
interest
despit
recent
deplet
antithymocyt
globulin
prior
transplant
second
case
week
prior
present
mer
cov
pneumonia
patient
rel
mild
ill
excel
clinic
recoveri
posit
outcom
may
relat
part
patient
young
age
factor
may
posit
impact
outcom
determin
singl
case
none
patient
contact
similarli
ill
patient
howev
second
patient
start
exhibit
symptom
day
discharg
hospit
infect
may
nosocomi
sourc
nosocomi
transmiss
major
obstacl
control
mer
infect
patient
place
isol
room
mer
diagnosi
suspect
transplant
program
respons
mer
cov
endem
adopt
chang
solid
organ
transplant
recipi
prior
schedul
outpati
clinic
visit
underw
initi
screen
triag
clinic
ensur
absenc
symptom
sign
suggest
mer
infect
addit
transplant
procedur
halt
time
epidem
month
conclus
report
mer
cov
pneumonia
two
renal
transplant
recipi
poor
outcom
one
case
favor
outcom
data
need
gain
better
understand
mer
cov
infect
solid
organ
transplant
recipi
author
manuscript
conflict
interest
disclos
describ
american
journal
transplant
